Debate continues over study of intraoperative rad therapy for breast cancer

A study published last year in the Lancet showing the merits of treating breast cancer with intraoperative radiation therapy (IORT) offered hope that the technique could be a safer alternative to traditional treatment. But not everybody is convinced.

The randomized controlled trial found IORT could prevent cancer from returning while also limiting the side effects seen with lengthier traditional treatments. However, some have criticized the design of the study and others say traditional radiation does a better job of controlling recurrence.

The Wall Street Journal checks in on the debate at the link below:

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.